DUBLIN--(BUSINESS WIRE)--The "Cancer Gene Therapy Daily" newsletter has been added to ResearchAndMarkets.com's offering.
Cancer Gene Therapy Daily features the latest peer-reviewed research and clinical trials in human gene therapy for cancers. An excellent resource for researchers, clinicians, and business professionals.
An annual subscription includes new issues Monday through Friday, 52 weeks out of the year.
For over 30 years, the analyst has monitored and reported on the world's emerging research and discoveries every day. With decades of reporting experience, they understand that great journalism demands transparent sourcing and journalistic integrity. Their original content is reported from sources of unparalleled depth according to the highest standards of journalism.
For more information about this newsletter visit https://www.researchandmarkets.com/r/ar90s2
